Your browser doesn't support javascript.
loading
Dose-Response Relationship Between Diltiazem and Tacrolimus and Its Safety in Renal Transplant Recipients.
Choong, C L; Wong, H S; Lee, F Y; Lee, C K; Kho, J V; Lai, Y X; Vikneswaran, T.
Affiliation
  • Choong CL; Pharmacy Department, Selayang Hospital, Selangor, Malaysia. Electronic address: ccling@moh.gov.my.
  • Wong HS; Nephrology Department, Selayang Hospital, Selangor, Malaysia.
  • Lee FY; Clinical Research Centre, Selayang Hospital, Selangor, Malaysia.
  • Lee CK; Pharmacy Department, Selayang Hospital, Selangor, Malaysia.
  • Kho JV; Pharmacy Department, Selayang Hospital, Selangor, Malaysia.
  • Lai YX; Pharmacy Department, Selayang Hospital, Selangor, Malaysia.
  • Vikneswaran T; Pharmacy Department, Selayang Hospital, Selangor, Malaysia.
Transplant Proc ; 50(8): 2515-2520, 2018 Oct.
Article in En | MEDLINE | ID: mdl-30316389
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcium Channel Blockers / Diltiazem / Kidney Transplantation / Tacrolimus / Immunosuppressive Agents Type of study: Observational_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Transplant Proc Year: 2018 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcium Channel Blockers / Diltiazem / Kidney Transplantation / Tacrolimus / Immunosuppressive Agents Type of study: Observational_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Transplant Proc Year: 2018 Document type: Article Country of publication: Estados Unidos